Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Microsatellite Stable Rectal Carcinoma 1Melanoma 1Hemangiosarcoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 24Fluorouracil 20Capecitabine 16pembrolizumab 15Nivolumab 15Leucovorin 13Trastuzumab 9fludarabine 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8S 1 (combination) 7trastuzumab deruxtecan 6Specimen Handling 6Cisplatin 6Magnetic Resonance Spectroscopy 5Bevacizumab 5zolbetuximab 4Irinotecan 4Biopsy 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomach Neoplasms × balstilimab × 90 days × Clear all
NCT06251973 2026-05-15

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
20 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT06346197 2026-04-21

CIME

Centre Leon Berard

Phase 3 Recruiting
132 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡